...
首页> 外文期刊>Haematologica >Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants | Haematologica
【24h】

Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants | Haematologica

机译:EDTA样品在接受口服抗凝剂的患者中凝血酶原时间测量中的应用血液学

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND AND OBJECTIVES: Oral anticoagulant therapy is commonly called for in health care. Hitherto sampling for prothrombin time (PT) has been measured on blood collected into a coagulation tube and diluted in citrate solution. Blood samples anticoagulated with EDTA are used for hematologic tests and the same sample could also be available for PT. DESIGN AND METHODS: We studied 107 patients on oral anticoagulant therapy. Samples were taken by from both coagulation tubes (citrate) and EDTA tubes. The PT from both samples was measured with an ACL 7000 analyzer and reported in seconds and as an international normalized ratio (INR). The regression equation between citrate and EDTA samples was calculated in both units. We studied the clinical significance of INR results from both sample types and compared the effect of different combined thromboplastin reagents on the correlation equation between citrate and EDTA samples. RESULTS: The regression equation for PT by Owren's PT reagent from citrate (y) and EDTA (x) plasma was y = 1.11 x -0.24 INR, R(2)= 0.99. We observed no clinically significant difference between INR results from citrate and EDTA samples using the regression equation for INR calculation from EDTA samples. ISI depends on sample type (dilution, anticoagulant) and the difference is 0.117, 10%. We calculated ISI for EDTA samples and no clinically significant difference was seen between citrate and EDTA INR results. INTERPRETATION AND CONCLUSIONS: A good correlation was observed between INR results with citrate and EDTA samples from patients receiving oral anticoagulants using Owren's PT reagent with the same citrate calibration. Using the regression equation (INR or sec) for analysis of INR results from EDTA samples is clinically acceptable and offers the possibility of using EDTA samples for PT measurement with citrate calibrators. Reagent international sensitivity index (ISI) values for citrate and EDTA samples differ from each other. ISI determination for EDTA samples requires mathematical calculation of EDTA ISI as in the present study or EDTA-based ISI calibrators. The regression equation for INR from citrate and EDTA samples depended on the reagent used, not only on sample dilution or anticoagulant.
机译:背景与目的:口服抗凝治疗在医疗保健中是普遍需要的。迄今为止,已经对收集到凝血管中并稀释在柠檬酸盐溶液中的血液进行了凝血酶原时间(PT)的采样。 EDTA抗凝的血液样本用于血液学检查,同样的样本也可用于PT。设计与方法:我们研究了107名接受口服抗凝治疗的患者。从凝结管(柠檬酸盐)和EDTA管中取样。用ACL 7000分析仪测量两个样品的PT,以秒为单位报告,并以国际标准化比(INR)表示。柠檬酸和EDTA样品之间的回归方程以两种单位计算。我们研究了两种样品类型的INR结果的临床意义,并比较了不同组合的凝血活酶试剂对柠檬酸盐和EDTA样品之间相关方程的影响。结果:Owren PT试剂从柠檬酸盐(y)和EDTA(x)血浆中PT的回归方程为y = 1.11 x -0.24 INR,R(2)= 0.99。我们使用从EDTA样品计算INR的回归方程,观察到柠檬酸盐和EDTA样品的INR结果之间在临床上无显着差异。 ISI取决于样品类型(稀释,抗凝剂),差异为0.117,即10%。我们计算了EDTA样品的ISI,柠檬酸盐和EDTA INR结果之间无临床显着差异。解释和结论:在使用相同的柠檬酸盐校准品的Owren PT试剂接受口服抗凝剂的患者中,柠檬酸盐和EDTA样品的柠檬酸盐和EDTA样品的INR结果之间存在良好的相关性。使用回归方程(INR或sec)分析EDTA样品的INR结果在临床上是可以接受的,并提供了使用EDTA样品通过柠檬酸盐校准剂进行PT测量的可能性。柠檬酸盐和EDTA样品的试剂国际敏感性指数(ISI)值互不相同。 EDTA样品的ISI测定需要像本研究中那样对EDTA ISI进行数学计算或基于EDTA的ISI校准器。柠檬酸盐和EDTA样品中INR的回归方程取决于所用试剂,而不仅取决于样品稀释度或抗凝剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号